# Clinical Efficacy and Safety of Compound Methyl Salicylate Liniment

> **NCT03362216** · NA · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 216 (actual)

## Conditions studied

- Soft Tissue Injuries

## Interventions

- **DRUG:** Compound Methyl Salicylate Liniment
- **DRUG:** Diclofenac Sodium Liniment

## Key facts

- **NCT ID:** NCT03362216
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-07
- **Primary completion:** 2009-05-22
- **Final completion:** 2009-06-12
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2017-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03362216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03362216, "Clinical Efficacy and Safety of Compound Methyl Salicylate Liniment". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03362216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*